Shweta A Raina1,2, David E Alonzo3,4, Geoff G Z Zhang3, Yi Gao3,5, Lynne S Taylor6. 1. Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, 575 Stadium Mall Drive, West Lafayette, Indiana, 47907, USA. 2. Manufacturing Science and Technology, AbbVie Inc, North Chicago, Illinois, USA. 3. Drug Product Development, Research and Development, AbbVie Inc, North Chicago, Illinois, USA. 4. Formulation & Process Development, Gilead Sciences, Inc, Foster City, California, USA. 5. Analytical Sciences, Manufacturing Science and Technology, AbbVie Inc, North Chicago, Illinois, USA. 6. Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, 575 Stadium Mall Drive, West Lafayette, Indiana, 47907, USA. lstaylor@purdue.edu.
Abstract
PURPOSE: Highly supersaturated aqueous solutions of poorly soluble compounds can undergo liquid-liquid phase separation (LLPS) when the concentration exceeds the "amorphous solubility". This phenomenon has been widely observed during high throughput screening of new molecular entities as well as during the dissolution of amorphous solid dispersions. In this study, we have evaluated the use of environment-sensitive fluorescence probes to investigate the formation and properties of the non-crystalline drug-rich aggregates formed in aqueous solutions as a result of LLPS. METHODS: Six different environment-sensitive fluorophores were employed to study LLPS in highly supersaturated solutions of several model compounds, all dihydropyridine derivatives. RESULTS: Each fluoroprobe exhibited a large hypsochromic shift with decreasing environment polarity. Upon drug aggregate formation, the probes partitioned into the drug-rich phase and exhibited changes in emission wavelength and intensity consistent with sensing a lower polarity environment. The LLPS onset concentrations determined using the fluorescence measurements were in good agreement with light scattering measurements as well as theoretically estimated amorphous solubility values. CONCLUSIONS: Environment-sensitive fluorescence probes are useful to help understand the phase behavior of highly supersaturated aqueous solutions, which in turn is important in the context of developing enabling formulations for poorly soluble compounds.
PURPOSE: Highly supersaturated aqueous solutions of poorly soluble compounds can undergo liquid-liquid phase separation (LLPS) when the concentration exceeds the "amorphous solubility". This phenomenon has been widely observed during high throughput screening of new molecular entities as well as during the dissolution of amorphous solid dispersions. In this study, we have evaluated the use of environment-sensitive fluorescence probes to investigate the formation and properties of the non-crystalline drug-rich aggregates formed in aqueous solutions as a result of LLPS. METHODS: Six different environment-sensitive fluorophores were employed to study LLPS in highly supersaturated solutions of several model compounds, all dihydropyridine derivatives. RESULTS: Each fluoroprobe exhibited a large hypsochromic shift with decreasing environment polarity. Upon drug aggregate formation, the probes partitioned into the drug-rich phase and exhibited changes in emission wavelength and intensity consistent with sensing a lower polarity environment. The LLPS onset concentrations determined using the fluorescence measurements were in good agreement with light scattering measurements as well as theoretically estimated amorphous solubility values. CONCLUSIONS: Environment-sensitive fluorescence probes are useful to help understand the phase behavior of highly supersaturated aqueous solutions, which in turn is important in the context of developing enabling formulations for poorly soluble compounds.
Authors: Bernard Van Eerdenbrugh; Shweta Raina; Yi-Ling Hsieh; Patrick Augustijns; Lynne S Taylor Journal: Pharm Res Date: 2013-11-23 Impact factor: 4.200
Authors: Kerstin J Frank; Ulrich Westedt; Karin M Rosenblatt; Peter Hölig; Jörg Rosenberg; Markus Mägerlein; Gert Fricker; Martin Brandl Journal: J Pharm Sci Date: 2014-04-24 Impact factor: 3.534
Authors: Dwayne T Friesen; Ravi Shanker; Marshall Crew; Daniel T Smithey; W J Curatolo; J A S Nightingale Journal: Mol Pharm Date: 2008 Nov-Dec Impact factor: 4.939
Authors: Hitesh S Purohit; James D Ormes; Sugandha Saboo; Yongchao Su; Matthew S Lamm; Amanda K P Mann; Lynne S Taylor Journal: Pharm Res Date: 2017-04-28 Impact factor: 4.200
Authors: Da Duan; Hayarpi Torosyan; Daniel Elnatan; Christopher K McLaughlin; Jennifer Logie; Molly S Shoichet; David A Agard; Brian K Shoichet Journal: ACS Chem Biol Date: 2016-12-16 Impact factor: 5.100
Authors: Kaijie Qian; Lorenzo Stella; David S Jones; Gavin P Andrews; Huachuan Du; Yiwei Tian Journal: Pharmaceutics Date: 2021-06-15 Impact factor: 6.321